BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34674592)

  • 1. Feasibility and acceptability of a Whole-Body hyperthermia (WBH) protocol.
    Mason AE; Fisher SM; Chowdhary A; Guvva E; Veasna D; Floyd E; Fender SB; Raison C
    Int J Hyperthermia; 2021; 38(1):1529-1535. PubMed ID: 34674592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and acceptability of an integrated mind-body intervention for depression: whole-body hyperthermia (WBH) and cognitive behavioral therapy (CBT).
    Mason AE; Chowdhary A; Hartogensis W; Siwik CJ; Lupesko-Persky O; Pandya LS; Roberts S; Anglo C; Moran PJ; Nelson JC; Lowry CA; Patrick RP; Raison CL; Hecht FM
    Int J Hyperthermia; 2024; 41(1):2351459. PubMed ID: 38743265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Body Hyperthermia for the Treatment of Major Depressive Disorder: A Randomized Clinical Trial.
    Janssen CW; Lowry CA; Mehl MR; Allen JJ; Kelly KL; Gartner DE; Medrano A; Begay TK; Rentscher K; White JJ; Fridman A; Roberts LJ; Robbins ML; Hanusch KU; Cole SP; Raison CL
    JAMA Psychiatry; 2016 Aug; 73(8):789-95. PubMed ID: 27172277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of plasma cytokines and antidepressant response following mild-intensity whole-body hyperthermia in major depressive disorder.
    Flux MC; Smith DG; Allen JJB; Mehl MR; Medrano A; Begay TK; Middlemist BH; Marquart BM; Cole SP; Sauder CJ; Lowry CA; Raison CL
    Transl Psychiatry; 2023 Apr; 13(1):132. PubMed ID: 37085494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body hyperthermia combined with hyperfractionated irradiation of the thorax in dog: acute physiological response.
    McChesney Gillette S; Dawson CA; Scott RJ; Rickaby DA; Powers BE; Johnston MR; Chen C; Gillette EL
    Int J Hyperthermia; 1993; 9(3):369-82. PubMed ID: 8515140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study.
    Hegewisch-Becker S; Gruber Y; Corovic A; Pichlmeier U; Atanackovic D; Nierhaus A; Hossfeld DK
    Ann Oncol; 2002 Aug; 13(8):1197-204. PubMed ID: 12181242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of whole-body hyperthermia interventions on mood and depression - are we ready for recommendations for clinical application?
    Hanusch KU; Janssen CW
    Int J Hyperthermia; 2019; 36(1):573-581. PubMed ID: 31159624
    [No Abstract]   [Full Text] [Related]  

  • 8. Current status of radiant whole-body hyperthermia at temperatures >41.5 degrees C and practical guidelines for the treatment of adults. The German 'Interdisciplinary Working Group on Hyperthermia'.
    Hildebrandt B; Hegewisch-Becker S; Kerner T; Nierhaus A; Bakhshandeh-Bath A; Janni W; Zumschlinge R; Sommer H; Riess H; Wust P;
    Int J Hyperthermia; 2005 Mar; 21(2):169-83. PubMed ID: 15764358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of temperatures in canine solid tumours during local and whole-body hyperthermia administered alone and simultaneously.
    Thrall DE; Dewhirst MW; Page RL; Samulski TV; McLeod DA; Oleson JR
    Int J Hyperthermia; 1990; 6(2):305-17. PubMed ID: 2324571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild Water-Filtered Infrared-A Whole-Body Hyperthermia Reduces Pain in Patients with Fibromyalgia Syndrome-A Randomized Sham-Controlled Trial.
    Langhorst J; Koch AK; Kehm C; Öznur Ö; Engler H; Häuser W
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.
    Robins HI; Rushing D; Kutz M; Tutsch KD; Tiggelaar CL; Paul D; Spriggs D; Kraemer C; Gillis W; Feierabend C; Arzoomanian RZ; Longo W; Alberti D; d'Oleire F; Qu RP; Wilding G; Stewart JA
    J Clin Oncol; 1997 Jan; 15(1):158-64. PubMed ID: 8996137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body hyperthermia with water-filtered infrared radiation: technical-physical aspects and clinical experiences.
    Wehner H; von Ardenne A; Kaltofen S
    Int J Hyperthermia; 2001; 17(1):19-30. PubMed ID: 11212877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inspired anaesthetic gas humidification improves thermal uniformity during canine whole body hyperthermia.
    Meyer RE; Berry CR; Lee JJ; Dodge RK; Page RL; Thrall DE
    Int J Hyperthermia; 1995; 11(3):397-407. PubMed ID: 7636326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas.
    Thrall DE; Prescott DM; Samulski TV; Rosner GL; Denman DL; Legorreta RL; Dodge RK; Page RL; Cline JM; Lee J; Case BC; Evans SM; Oleson JR; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1087-96. PubMed ID: 8600092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor oxygenation under combined whole-body-hyperthermia and polychemotherapy in a case of recurrent carcinoma of the oral cavity.
    Sagowski C; Jaehne M; Kehrl W; Hegewisch-Becker S; Wenzel S; Panse J; Nierhaus A
    Eur Arch Otorhinolaryngol; 2002 Jan; 259(1):27-31. PubMed ID: 11954922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal distribution, physiological effects and toxicities of extracorporeally induced whole-body hyperthermia in a pig model.
    Lassche G; Frenzel T; Mignot MH; Jonker MA; van der Hoeven JG; van Herpen CML; Scheffer GJ
    Physiol Rep; 2020 Feb; 8(4):e14366. PubMed ID: 32097540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer.
    Douwes F; BogoviC J; Douwes O; Migeod F; Grote C
    Int J Clin Oncol; 2004 Apr; 9(2):85-91. PubMed ID: 15108039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole body hyperthermia induction of soluble tumor necrosis factor receptors: implications for rheumatoid diseases.
    Robins HI; Grosen E; Katschinski DM; Longo W; Tiggelaar CL; Kutz M; Winawer J; Graziano F
    J Rheumatol; 1999 Dec; 26(12):2513-6. PubMed ID: 10606355
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.